These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14607676)

  • 1. Influence of portal pressure change on intestinal permeability in patients with portal hypertension.
    Xu WH; Wu XJ; Li JS
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):510-4. PubMed ID: 14607676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influences of portal pressure change on intestinal permeability in patients with portal hypertension].
    Xu W; Wu X; Li J
    Zhonghua Wai Ke Za Zhi; 2002 Mar; 40(3):201-4. PubMed ID: 11955416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined TIPSS with modified Sugiura operation for portal hypertension].
    Wu X; Li J; Cao J; Wu X; Han J
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):216-8. PubMed ID: 11829823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of TIPS, a modified Sugiura procedure and TIPS plus a modified Sugiura procedure for portal hypertension].
    Wu X; Cao J; Wu X; Han J; Li J
    Zhonghua Wai Ke Za Zhi; 2000 Feb; 38(2):98-100. PubMed ID: 11831998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azygos blood flow: phase contrast quantitation in volunteers and patients with portal hypertension pre- and postintrahepatic shunt placement.
    Debatin JF; Zahner B; Meyenberger C; Romanowski B; Schöpke W; Marincek B; Fuchs WA
    Hepatology; 1996 Nov; 24(5):1109-15. PubMed ID: 8903384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term results of TIPS, TIPS with CVO and combined TIPS and portal azygous disconnection for the treatment of portal hypertension].
    Wu XJ; Cao JM; Han JM; Li JS
    Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):446-9. PubMed ID: 19595233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of transjugular intrahepatic portosystemic stent shunts on portal and systemic hemodynamics of patients with portal hypertension].
    Wu X; Li J; Cao J; Wu X; Ni X
    Zhonghua Wai Ke Za Zhi; 1998 Jun; 36(6):342-4. PubMed ID: 11825406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined splenorenal shunt devascularization and devascularization only on hemodynamics of the portal venous system in patients with portal hypertension.
    Cao H; Hua R; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):385-8. PubMed ID: 16109521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
    Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
    J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding.
    Monescillo A; Martínez-Lagares F; Ruiz-del-Arbol L; Sierra A; Guevara C; Jiménez E; Marrero JM; Buceta E; Sánchez J; Castellot A; Peñate M; Cruz A; Peña E
    Hepatology; 2004 Oct; 40(4):793-801. PubMed ID: 15382120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
    Nair S; Singh R; Yoselewitz M
    J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular portosystemic shunt in chronic portal vein occlusion: importance of segmental portal hypertension in cavernous transformation of the portal vein.
    Walser EM; Soloway R; Raza SA; Gill A
    J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):373-8. PubMed ID: 16517786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlative study between portal vein pressure and portal hemodynamics in patients with portal hypertension].
    Liu Y; Li L; Yu Z; Liu Q; Li Z; Wang Y; Zhang Q
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):135-7. PubMed ID: 11983136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS.
    Holland-Fischer P; Grønbæk H; Sandahl TD; Moestrup SK; Riggio O; Ridola L; Aagaard NK; Møller HJ; Vilstrup H
    Gut; 2011 Oct; 60(10):1389-93. PubMed ID: 21572121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of direct portal vein puncture portography with modified TIPS treatment in patients with portal hypertension and gastro-esophageal varices bleeding].
    Li CQ; Xu DH; Xu DZ; Li HL; Chu JG; Li XM; Ma Y; Jing QH
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):403-6. PubMed ID: 15975269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of transjugular intrahepatic portosystemic shunt for variceal bleeding in hepatocellular carcinoma patients with portal vein thrombosis].
    Chung WJ; Jang BK; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Kim YH; Kim YJ
    Korean J Hepatol; 2005 Jun; 11(2):157-63. PubMed ID: 15980674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal flow and arterioportal shunting after transjugular intrahepatic portosystemic shunt creation.
    Itkin M; Trerotola SO; Stavropoulos SW; Patel A; Mondschein JI; Soulen MC; Tuite CM; Shlansky-Goldberg RD; Faust TW; Reddy KR; Solomon JA; Clark TW
    J Vasc Interv Radiol; 2006 Jan; 17(1):55-62. PubMed ID: 16415133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
    Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
    Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of transjugular intrahepatic portosystemic shunts in liver-transplant recipients.
    Choi DX; Jain AB; Orloff MS
    J Am Coll Surg; 2009 Apr; 208(4):539-46. PubMed ID: 19476787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients.
    Praticò D; Rossi E; Merli M; Riggio O; FitzGerald GA; Violi F
    J Investig Med; 1998 Dec; 46(9):430-4. PubMed ID: 9861778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.